Literature DB >> 21586621

Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children.

Ryan M Swinney1, Joke Beuten, Anderson B Collier, Tina T-L Chen, Naomi J Winick, Brad H Pollock, Gail E Tomlinson.   

Abstract

BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. The U.S. Surveillance Epidemiology and End Results (SEER) registry reports that Hispanic children have the highest incidence of ALL, however, it is unclear if this is due to genetic factors, unique environmental exposures, or both. Previous reports have shown an association between CYP1A1 variants and ALL.
METHODS: To explore the contribution of CYP1A1 polymorphisms to ALL susceptibility in different ethnic groups, we conducted a case-control analysis in Caucasian, Hispanic, and African-American children.
RESULTS: Increased risk of developing ALL was found in the whole sample group for homozygosity of variant alleles at CYP1A1*2C (OR 2.51, 95% CI 1.18-5.33, P = 0.016) and CYP1A1*2B (OR 3.24, 95% CI 1.43-7.34, P = 0.005). Stratified analyses showed increased risks in the Hispanic group (CYP1A1*2A, OR 2.70, 95% CI 1.27-5.74, P = 0.010; CYP1A1*2C, OR 2.47, 95% CI 1.13-5.38, P = 0.023; and CYP1A1*2B, OR 3.28, 95% CI 1.40-7.69, P = 0.006) but not for the other ethnic groups. Hispanic control subjects were significantly more likely to be carriers of variant alleles as compared to Caucasians (P < 0.0001) and African Americans (P = 0.005).
CONCLUSIONS: Our study suggests that polymorphisms in CYP1A1 may contribute to the increased risk of ALL in Hispanic children due to both their impact on leukemia susceptibility and the increased prevalence of the at-risk alleles in the Hispanic population. IMPACT: Our study provides a novel and specific link between CYP1A1 polymorphisms and ethnic influence on ALL risk that may help explain varying susceptibilities across groups to environmental toxins. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586621     DOI: 10.1158/1055-9965.EPI-10-1265

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  15 in total

1.  Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer.

Authors:  Leticia B A Rangel; Jodi L Taraba; Christopher R Frei; Lon Smith; Gladys Rodriguez; John G Kuhn
Journal:  Breast Cancer Res Treat       Date:  2014-11-14       Impact factor: 4.872

2.  XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Authors:  Yi Huang; Denghai Xie; Nana Tang; Jishi Wang; Xiaoqing Zeng; Peng Zhao; Ling He
Journal:  Tumour Biol       Date:  2013-08-30

3.  Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane.

Authors:  Lyndsey E Shorey; Erin P Madeen; Lauren L Atwell; Emily Ho; Christiane V Löhr; Clifford B Pereira; Roderick H Dashwood; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

Review 4.  Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Atsushi Manabe; Shuki Mizutani
Journal:  Int J Hematol       Date:  2012-12-13       Impact factor: 2.490

5.  Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia.

Authors:  Julie R Gilbert; Himalee S Sabnis; Roman Radzievski; Deon B Doxie; Deborah DeRyckere; Sharon M Castellino; Kavita Dhodapkar
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

6.  Association of serum aryl hydrocarbon receptor activity and RBC omega-3 polyunsaturated fatty acids with flow-mediated dilation in healthy, young Hispanic cigarette smokers.

Authors:  Elani F Wiest; Alex Warneke; Mary T Walsh; Mark Langsfeld; Joe Anderson; Mary K Walker
Journal:  Toxicol Lett       Date:  2014-12-04       Impact factor: 4.372

7.  Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk.

Authors:  Mary M Jenkins; Jennita Reefhuis; Margaret L Gallagher; Jennifer G Mulle; Thomas J Hoffmann; Deborah A Koontz; Cynthia Sturchio; Sonja A Rasmussen; John S Witte; Patricia Richter; Margaret A Honein
Journal:  Am J Med Genet A       Date:  2014-03-25       Impact factor: 2.802

8.  A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility.

Authors:  Erin C Peckham-Gregory; Rikhia Chakraborty; Michael E Scheurer; John W Belmont; Harshal Abhyankar; Amel G Sengal; Brooks P Scull; Olive Eckstein; Daniel J Zinn; Louisa Mayer; Albert Shih; Miriam Merad; D Williams Parsons; Kenneth L McClain; Philip J Lupo; Carl E Allen
Journal:  Blood       Date:  2017-09-21       Impact factor: 22.113

9.  Association between CYP1A1 Ile462Val variation and acute leukemia risk: meta-analyses including 2164 cases and 4160 controls.

Authors:  Wenlei Zhuo; Liang Zhang; Bo Zhu; Zhiqun Qiu; Zhengtang Chen
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

10.  The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies.

Authors:  Fang Wang; Qian Zhao; Hai-Rong He; Ya-Jing Zhai; Jun Lu; Hai-Bo Hu; Jin-Song Zhou; Yong-Hua Yang; Yuan-Jie Li
Journal:  Onco Targets Ther       Date:  2015-11-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.